Literature DB >> 34123950

Chronic Neutrophilic Leukemia with Monocytosis.

Laila Alromaih1, Leena Abdalla1, Arifa Jamal1, Assim Osman1, Mohanad Bakkar1, Lina Abdul Samad2, Tamer M Ahmed3.   

Abstract

Chronic neutrophilic leukaemia is a very rare disease with diagnosis based on persistent leucocytosis >25×103/μl and monocytes <1×103/μl. The revised WHO criteria 2016 included CSF3R gene mutations as a diagnostic finding. We report the case of a 77-year-old man who was found to have asymptomatic persistent mature neutrophilic leucocytosis with monocytosis. Molecular study confirmed the presence of a CSF3R gene mutation in the absence of morphological or genetic features of myelodysplasia or other forms of myelodysplastic syndrome. The patient's medical history was significant for coronary artery disease, hypertension, chronic obstructive pulmonary disease, bilateral cystic bronchiectasis, moderate pulmonary hypertension, tuberculosis treated 27 years previously, hypothyroidism, and a thyroid nodule. He had hepatosplenomegaly but no lymphadenopathy, and no other malignancy was seen on computed tomography (CT) scanning. At the time of evaluation, he was free of symptoms and had no evidence of infection or drug-induced leucocytosis. The patient was referred to an oncology centre and treated with hydroxyurea and subsequently azacitidine. However, he developed pancytopenia with bone marrow aplasia. He died with neutropenia sepsis. The presence of persistent monocytosis in this case created a diagnostic dilemma as to whether the disease was a variant of chronic neutrophilic leukaemia or was reactive monocytosis. LEARNING POINTS: The presence of a CSF3R gene mutation is diagnostic for chronic neutrophilic leukaemia (CNL).The monocytosis in this patient might have been a new variant of CNL. © EFIM 2021.

Entities:  

Keywords:  Chronic neutrophilic leukaemia; atypical chronic myeloid leukaemia; chronic myelomonocytic leukaemia; colony-stimulating factor 3 receptor mutation; myeloproliferative neoplasm

Year:  2021        PMID: 34123950      PMCID: PMC8191347          DOI: 10.12890/2021_002595

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  5 in total

Review 1.  Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.

Authors:  Natasha Szuber; Michelle Elliott; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2019-12-30       Impact factor: 10.047

Review 2.  Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.

Authors:  Michelle A Elliott; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2018-08       Impact factor: 10.047

3.  The 2016 Revision to the World Health Organization Classification of Myelodysplastic Syndromes.

Authors:  Ming Hong; Guangsheng He
Journal:  J Transl Int Med       Date:  2017-09-30

Review 4.  Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.

Authors:  Mrinal M Patnaik; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2018-06       Impact factor: 10.047

Review 5.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.